JIN, Thong-Gyu,CHUNG, Yo Kyung,PAIK, Sang Hoon,PARK, Yoo Chang,SEO, Jinwook,CHOI, Yong Woon,SON, Jong Mun,KIM, Yong-Chul
申请号：
AU2016201487
公开号：
AU2016201487A1
申请日:
2016.03.08
申请国别(地区):
AU
年份:
2016
代理人:
摘要：
#$%^&*AU2016201487A120160324.pdf#####Abstract Disclosed is a composition comprising recombinant iduronate-2-sulfatase (IDS). The glycosylation pattern and formylglycine content of the IDS composition are different from those of Elaprase and have superior pharmaceutical efficacy and are safer than the conventional agent and thus can be effectively used for the therapy of Hunter syndrome.
